BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Monday reported second-quarter profit of $1.03 billion.
The Boston-based company said it had net income of $3.99 per share. Earnings, adjusted for one-time gains and costs, were $4.52 per share.
The results beat Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $4.24 per share.
The drugmaker posted revenue of $2.96 billion in the period, also surpassing Street forecasts. Eleven analysts surveyed by Zacks expected $2.89 billion.
Vertex expects full-year revenue in the range of $11.85 billion to $12 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VRTX at https://www.zacks.com/ap/VRTX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
